Contineum Therapeutics Ownership | Who Owns Contineum Therapeutics?
Contineum Therapeutics Ownership Summary
Contineum Therapeutics is owned by 82.11% institutional investors, 0.52% insiders, and 17.36% retail investors. Suvretta capital management is the largest institutional shareholder, holding 10.26% of CTNM shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.93% of its assets in Contineum Therapeutics shares.
CTNM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Contineum Therapeutics | 82.11% | 0.52% | 17.36% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 2.84M | 10.26% | $37.11M |
| Janus henderson group | 2.73M | 9.87% | $35.59M |
| Fmr | 2.61M | 6.97% | $35.03M |
| Balyasny asset management | 1.69M | 6.09% | $22.01M |
| Blackrock funding, inc. /de | 2.22M | 5.93% | $29.84M |
| Millennium management | 1.54M | 5.54% | $20.05M |
| Johnson & johnson | 1.98M | 5.28% | $26.56M |
| Franklin resources | 1.70M | 4.55% | $16.69M |
| Perceptive advisors | 1.26M | 4.53% | $16.40M |
| Vanguard group | 1.27M | 4.52% | $14.53M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 1.29M | 15.90% | $17.35M |
| Red tree management | 638.16K | 7.45% | $8.33M |
| Sectoral asset management | 689.59K | 5.88% | $9.25M |
| Johnson & johnson | 1.98M | 3.49% | $26.56M |
| Great point partners | 800.20K | 2.40% | $10.45M |
| Verdad advisers, lp | 86.03K | 1.26% | $1.12M |
| Suvretta capital management | 2.84M | 0.95% | $37.11M |
| Ikarian capital | 807.87K | 0.86% | $10.55M |
| Boxer capital management | 494.00K | 0.85% | $6.45M |
| Highvista strategies | 217.79K | 0.77% | $2.92M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 2.61M | 0.00% | 1.57M |
| Versant venture management | 1.29M | 15.90% | 750.00K |
| Millennium management | 1.54M | 0.01% | 704.76K |
| Ikarian capital | 807.87K | 0.86% | 525.00K |
| State street | 808.51K | 0.00% | 382.61K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | - | - | -1.42M |
| Ra capital management | - | - | -1.30M |
| Commodore capital lp | - | - | -816.33K |
| Point72 asset management | 84.89K | 0.00% | -674.34K |
| Saturn v capital management | - | - | -319.35K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Citadel advisors | 350.20K | 0.00% | 350.20K | $4.57M |
| Highvista strategies | 217.79K | 0.77% | 217.79K | $2.92M |
| Verdad advisers, lp | 86.03K | 1.26% | 86.03K | $1.12M |
| Wellington management group llp | 55.61K | 0.00% | 55.61K | $726.25K |
| Profund advisors | 37.85K | 0.01% | 37.85K | $507.96K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Sbi securities | -1.00 |
| Caitong asset management | -19.00 |
| Cubist systematic strategies | -24.00 |
| Golden state wealth management | -27.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 105 | 15.38% | 30,765,819 | 0.69% | 82 | 1.23% | 64 | 25.49% | 18 | -14.29% |
| Mar 31, 2026 | 91 | 10.98% | 30,555,242 | 3.22% | 110 | 0.99% | 51 | -13.56% | 21 | 133.33% |
| Dec 31, 2025 | 10 | -83.87% | 2,281,353 | -86.95% | 8 | 0.18% | 7 | -77.42% | 1 | -94.74% |
| Sep 30, 2025 | 12 | -82.86% | 2,288,931 | -83.48% | 8 | 0.31% | 7 | -82.93% | 3 | -85.71% |
| Jun 30, 2025 | 69 | 13.11% | 13,845,129 | 2.06% | 53 | 1.94% | 40 | 42.86% | 21 | 16.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 1.10M | 2.93% | - |
| Vanguard Total Stock Mkt Idx Inv | 982.26K | 2.63% | 71.60K |
| Vanguard Morn Total Stk Mkt Idx Investor | 982.26K | 2.61% | 71.60K |
| Vanguard MStar Total Stk Mkt Idx Invest | 982.26K | 2.61% | - |
| iShares Russell 2000 ETF | 697.93K | 1.78% | - |
| Franklin Biotechnology Discovery A | 601.16K | 1.60% | - |
| Fidelity Select Pharmaceuticals Port | 614.20K | 1.56% | 614.20K |
| Fidelity Advisor Biotechnology I | 481.90K | 1.23% | 257.00K |
| Fidelity Select Health Care | 450.00K | 1.20% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 303.19K | 0.81% | -5.45K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 08, 2026 | Stengone Carmine N. | CEO and President | Sell | $41.14K |
| Aug 03, 2026 | Stengone Carmine N. | CEO and President | Sell | $40.03K |
| Jul 09, 2026 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $400.00 |
| Jul 08, 2026 | Stengone Carmine N. | CEO and President | Sell | $40.00K |
| Jun 30, 2026 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $462.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 6 |
| 2026 Q2 | - | 7 |
| 2026 Q1 | - | 15 |
| 2025 Q4 | - | 2 |
| 2025 Q2 | - | - |
CTNM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools